We're hiring a data and partnerships assistant
Are you passionate about technology and looking for an exciting opportunity to kick-start your career...
07 Apr 2024
In a groundbreaking study, UK general practitioners (GPs) have expressed a strong desire to prescribe assistive technologies for dementia patients. The goal? To enhance independence and extend lives. This research, conducted by the Longitude Prize on Dementia, sheds light on the urgent need for innovative solutions in dementia care.
GP Enthusiasm: Over two-thirds (67%) of UK GPs are keen to prescribe tech tools specifically designed for dementia patients. These assistive technologies aim to empower individuals, allowing them to remain in their own homes while maintaining a fulfilling life.
Independence Matters: A staggering 88% of GPs believe that people with dementia who can continue living independently at home experience more fulfilling lives. Moreover, 77% of these doctors are convinced that such independence contributes to longevity.
Existing Challenges: Despite existing technologies, there's room for improvement. Most current solutions focus on monitoring patients rather than actively supporting their day-to-day activities. This gap frustrates 86% of surveyed GPs, who recognize the need for more effective tools.
Enter Lola—the digital companion with immense potential. Here's how Lola can revolutionize dementia care:
As the dementia epidemic grows, we must embrace technology, and AI can be a big part of the shift to innovation in the space. By empowering patients and bridging gaps in care, we can extend lives and enhance well-being. Lola isn't just a digital companion; she's a lifeline for those navigating the complexities of dementia. Let's make independence and longevity a reality - one conversation at a time.